Dale J B, Beachey E H
J Exp Med. 1985 Jan 1;161(1):113-22. doi: 10.1084/jem.161.1.113.
We present evidence that a highly purified pepsin extract of type 5 streptococcal M protein (pep M5) contains at least three epitopes that are cross-reactive with sarcolemmal membrane proteins of human myocardium. The tissue-cross-reactive determinants of pep M5 are also partially shared with pep M6 and pep M19. Three rabbits immunized with a single 300 micrograms dose of pep M5 developed significant levels of heart-cross-reactive antibodies, as determined by indirect immunofluorescence tests. All three sera also contained antibodies that cross-reacted with pep M6 and pep M19. The heart tissue--specific antibodies that were eluted from sarcolemmal membranes opsonized types 5, 6, and 19 streptococci, indicating that they were directed against protective M protein epitopes on the surface of virulent organisms. Immunofluorescence inhibition tests, using purified M proteins as soluble inhibitors of heart-cross-reactive antibodies, revealed the number and M protein serotype distribution of the tissue-cross-reactive epitopes. Immunoblot analyses demonstrated the sarcolemmal membrane proteins containing the various cross-reactive antigenic determinants.
我们提供证据表明,5型链球菌M蛋白的高度纯化胃蛋白酶提取物(pep M5)含有至少三个与人心肌肌膜蛋白交叉反应的表位。pep M5的组织交叉反应决定簇也部分与pep M6和pep M19共有。用单次300微克剂量的pep M5免疫的三只兔子产生了显著水平的心脏交叉反应抗体,这通过间接免疫荧光试验确定。所有三份血清还含有与pep M6和pep M19交叉反应的抗体。从5型、6型和19型链球菌调理的肌膜洗脱的心脏组织特异性抗体,表明它们针对的是有毒生物体表面的保护性M蛋白表位。使用纯化的M蛋白作为心脏交叉反应抗体的可溶性抑制剂的免疫荧光抑制试验,揭示了组织交叉反应表位的数量和M蛋白血清型分布。免疫印迹分析证明了含有各种交叉反应抗原决定簇的肌膜蛋白。